{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:42:33Z","timestamp":1794008553783,"version":"4.8.0"},"reference-count":132,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22304094"],"award-info":[{"award-number":["22304094"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2025MS272"],"award-info":[{"award-number":["ZR2025MS272"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.critrevonc.2026.105448","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T06:53:08Z","timestamp":1782283988000},"page":"105448","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Targeting strategies of lipid nanoparticles for RNA therapeutics: From hepatic tropism to extrahepatic precision delivery"],"prefix":"10.1016","volume":"226","author":[{"given":"Xiao","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyue","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8555-9230","authenticated-orcid":false,"given":"Jianfei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105448_bib1","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41565-025-02108-7","article-title":"Spatiotemporal targeting of messenger RNA lipid nanoparticles to the endometrium for the treatment of reproductive disorders","volume":"21","author":"Abbasi","year":"2026","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.critrevonc.2026.105448_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113821","article-title":"Impact of pre-existing anti-polyethylene glycol (PEG) IgM on biodistribution and humoral response of intramuscularly administered PEGylated mRNA loaded lipid nanoparticle","volume":"383","author":"Abe","year":"2025","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105448_bib3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/17460441.2022.2155630","article-title":"A comprehensive update of siRNA delivery design strategies for targeted and effective gene silencing in gene therapy and other applications","volume":"18","author":"Abosalha","year":"2023","journal-title":"Expert. Opin. Drug. Discov."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105448_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105448_bib5","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","article-title":"The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs","volume":"14","author":"Akinc","year":"2019","journal-title":"Nat. Nanotechnol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105448_bib6","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nbt1402","article-title":"A combinatorial library of lipid-like materials for delivery of RNAi therapeutics","volume":"26","author":"Akinc","year":"2008","journal-title":"Nat. Biotechnol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105448_bib7","first-page":"749","article-title":"Folated-nanocarrier","volume":"10","author":"Al\u2011Musawi","year":"2018","journal-title":"paclitaxel Drug. Deliv. Leuk. Cancer Ther. J. Pharm. Sci. Res."},{"key":"10.1016\/j.critrevonc.2026.105448_bib8","doi-asserted-by":"crossref","DOI":"10.1063\/5.0092330","article-title":"Nanoformulation of intelligence polymeric nanocarrier for resveratrol targeted delivery and study its cytotoxic, apoptotic, and genetics effects in epidermoid carcinoma therapy","author":"Alnasraui","year":"2022","journal-title":"AIP Conf. Proc."},{"key":"10.1016\/j.critrevonc.2026.105448_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fmedt.2025.1591119","article-title":"Enhancing nucleic acid delivery by the integration of artificial intelligence into lipid nanoparticle formulation","volume":"7","author":"Amoako","year":"2025","journal-title":"Front. Med. Technol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105448_bib10","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1021\/bc100478k","article-title":"Novel method to label solid lipid nanoparticles with 64cu for positron emission tomography imaging","volume":"22","author":"Andreozzi","year":"2011","journal-title":"Bioconjug. Chem."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105448_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10143","article-title":"Nanoparticles in the clinic: An update","volume":"4","author":"Anselmo","year":"2019","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.critrevonc.2026.105448_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1718256","article-title":"Nanocarrier-based delivery of siRNA therapeutics in rheumatoid arthritis: immune mechanisms and translational perspectives","volume":"16","author":"Bai","year":"2025","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105448_bib13","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s10967-014-3258-z","article-title":"An easy and effective method for radiolabelling of solid lipid nanoparticles","volume":"302","author":"Banerjee","year":"2014","journal-title":"J. Radioanal. Nucl. Chem."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105448_bib14","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307799120","article-title":"Dynamic carriers for therapeutic RNA delivery","volume":"121","author":"Berger","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105448_bib15","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105448_bib16","doi-asserted-by":"crossref","first-page":"13993","DOI":"10.1021\/acsnano.1c05099","article-title":"Delivery of Oligonucleotide Therapeutics: Chemical Modifications, Lipid Nanoparticles, and Extracellular Vesicles","volume":"15","author":"Bost","year":"2021","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105448_bib17","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.apsb.2022.07.011","article-title":"Doxorubicin-conjugated siRNA lipid nanoparticles for combination cancer therapy","volume":"13","author":"Butowska","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105448_bib18","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1021\/acsami.9b15910","article-title":"Corona of Thorns: The Surface Chemistry-Mediated Protein Corona Perturbs the Recognition and Immune Response of Macrophages","volume":"12","author":"Cai","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"33","key":"10.1016\/j.critrevonc.2026.105448_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adw0730","article-title":"Lipid nanoparticles for mRNA delivery in brain via systemic administration","volume":"11","author":"Cao","year":"2025","journal-title":"Sci. Adv."},{"issue":"26","key":"10.1016\/j.critrevonc.2026.105448_bib20","doi-asserted-by":"crossref","first-page":"17267","DOI":"10.1021\/acsnano.4c04901","article-title":"Lipid Nanoparticular Codelivery System for Enhanced Antitumor Effects by Ferroptosis-Apoptosis Synergistic with Programmed Cell Death-Ligand 1 Downregulation","volume":"18","author":"Cao","year":"2024","journal-title":"ACS Nano"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105448_bib21","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1073\/pnas.0608582104","article-title":"Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles","volume":"104","author":"Cedervall","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105448_bib22","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41563-025-02331-6","article-title":"Peptide codes for organ-selective mRNA delivery","volume":"25","author":"Chang","year":"2026","journal-title":"Nat. Mater."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105448_bib23","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.4049\/jimmunol.1601896","article-title":"Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection","volume":"198","author":"Channappanavar","year":"2017","journal-title":"J. Immunol."},{"issue":"1-2","key":"10.1016\/j.critrevonc.2026.105448_bib24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijpharm.2006.02.015","article-title":"Microemulsion-based hydrogel formulation of ibuprofen for topical delivery","volume":"315","author":"Chen","year":"2006","journal-title":"Int. J. Pharm."},{"issue":"50","key":"10.1016\/j.critrevonc.2026.105448_bib25","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2309472120","article-title":"Combinatorial design of ionizable lipid nanoparticles for muscle-selective mRNA delivery with minimized off-target effects","volume":"120","author":"Chen","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105448_bib26","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrd4503","article-title":"A holistic approach to targeting disease with polymeric nanoparticles","volume":"14","author":"Cheng","year":"2015","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"18","key":"10.1016\/j.critrevonc.2026.105448_bib27","doi-asserted-by":"crossref","first-page":"15693","DOI":"10.1021\/jacs.5c03033","article-title":"Topologically Engineered Supramolecular Cyclolipid Nanoparticles: A Custom-Tailored Delivery System for Inhaled Combination Therapy","volume":"147","author":"Cheng","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"44","key":"10.1016\/j.critrevonc.2026.105448_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202407398","article-title":"Development of Organ Targeting Lipid Nanoparticles with Low Immunogenicity and Their Application in the Treatment of Pulmonary Fibrosis","volume":"63","author":"Cheng","year":"2024","journal-title":"Angew. Chem. Int. Ed."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105448_bib29","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105448_bib30","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1124\/dmd.113.055434","article-title":"Biodistribution and metabolism studies of lipid nanoparticle\u2013formulated internally [3H]-labeled siRNA in mice","volume":"42","author":"Christensen","year":"2014","journal-title":"Drug. Metab. Dispos."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105448_bib31","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1124\/dmd.122.000980","article-title":"Biodistribution of Lipid 5, mRNA, and Its Translated Protein Following Intravenous Administration of mRNA-Encapsulated Lipid Nanoparticles in Rats","volume":"51","author":"Ci","year":"2023","journal-title":"Drug. Metab. Dispos."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105448_bib32","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","article-title":"Lipid Nanoparticle Systems for Enabling Gene Therapies","volume":"25","author":"Cullis","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.critrevonc.2026.105448_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.722411","article-title":"Tuning the Immunostimulation Properties of Cationic Lipid Nanocarriers for Nucleic Acid Delivery","volume":"12","author":"Dey","year":"2021","journal-title":"Front. Immunol."},{"issue":"52","key":"10.1016\/j.critrevonc.2026.105448_bib34","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109256118","article-title":"On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles","volume":"118","author":"Dilliard","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.critrevonc.2026.105448_bib35","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jconrel.2023.07.058","article-title":"The interplay of quaternary ammonium lipid structure and protein corona on lung-specific mRNA delivery by selective organ targeting (SORT) nanoparticles","volume":"361","author":"Dilliard","year":"2023","journal-title":"J. Control. Release"},{"issue":"22","key":"10.1016\/j.critrevonc.2026.105448_bib36","doi-asserted-by":"crossref","first-page":"15085","DOI":"10.1021\/jacs.4c00451","article-title":"Multicomponent Synthesis of Imidazole-Based Ionizable Lipids for Highly Efficient and Spleen-Selective Messenger RNA Delivery","volume":"146","author":"Dong","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.critrevonc.2026.105448_bib37","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jconrel.2023.08.014","article-title":"Lipid nanoparticle-mediated messenger RNA delivery for ex vivo engineering of natural killer cells","volume":"361","author":"Douka","year":"2023","journal-title":"J. Control. Release"},{"issue":"33","key":"10.1016\/j.critrevonc.2026.105448_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201606944","article-title":"Synthesis and Biological Evaluation of Ionizable Lipid Materials for the In Vivo Delivery of Messenger RNA to B Lymphocytes","volume":"29","author":"Fenton","year":"2017","journal-title":"Adv. Mater."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105448_bib39","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1021\/acs.bioconjchem.0c00366","article-title":"The Biomolecular Corona of Lipid Nanoparticles for Gene Therapy","volume":"31","author":"Francia","year":"2020","journal-title":"Bioconjugate Chem."},{"issue":"45","key":"10.1016\/j.critrevonc.2026.105448_bib40","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2409569122","article-title":"Glycolipid nanoparticles target the spleen and detarget the liver without charge","volume":"122","author":"Gentry","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.critrevonc.2026.105448_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123671","article-title":"Investigating the functional contributions of phospholipids in selective organ targeting lipid nanoparticles","volume":"326","author":"Guerrero","year":"2026","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105448_bib42","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40580-026-00531-7","article-title":"Machine learning-driven exosome-mimetic lipid nanoparticles for tumor-specific targeting","volume":"13","author":"Ha","year":"2026","journal-title":"Nano Converg."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105448_bib43","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1186\/s12951-024-02972-w","article-title":"Navigating the intricate in-vivo journey of lipid nanoparticles tailored for the targeted delivery of RNA therapeutics: a quality-by-design approach","volume":"22","author":"Haghighi","year":"2024","journal-title":"J. Nanobiotechnol"},{"issue":"Pt 2","key":"10.1016\/j.critrevonc.2026.105448_bib44","article-title":"Zn-coordinated lipid nanoparticles synergistically enhance spleen-targeting delivery and elicit CD8(+) T cell-mediated cancer immunotherapy,","volume":"702","author":"Han","year":"2026","journal-title":"J. Colloid Interface Sci."},{"issue":"18","key":"10.1016\/j.critrevonc.2026.105448_bib45","article-title":"Advancing Cellular-Specific Delivery: Machine Learning Insights into Lipid Nanoparticles Design and Cellular Tropism","volume":"14","author":"Hanafy","year":"2025","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.critrevonc.2026.105448_bib46","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jconrel.2017.07.046","article-title":"pH-labile PEGylation of siRNA-loaded lipid nanoparticle improves active targeting and gene silencing activity in hepatocytes","volume":"262","author":"Hashiba","year":"2017","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105448_bib47","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1021\/acsabm.0c00242","article-title":"Matrix Metalloproteinase-Responsive PEGylated Lipid Nanoparticles for Controlled Drug Delivery in the Treatment of Rheumatoid Arthritis","volume":"3","author":"He","year":"2020","journal-title":"ACS Appl. Bio. Mater."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105448_bib48","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3390\/pharmaceutics17040459","article-title":"Predictive Lung- and Spleen-Targeted mRNA Delivery with Biodegradable Ionizable Lipids in Four-Component LNPs","volume":"17","author":"Heredero","year":"2025","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105448_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.add4623","article-title":"Peptide-guided lipid nanoparticles deliver mRNA to the neural retina of rodents and nonhuman primates","volume":"9","author":"Herrera\u2011Barrera","year":"2023","journal-title":"Sci. Adv."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105448_bib50","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.critrevonc.2026.105448_bib51","doi-asserted-by":"crossref","DOI":"10.34133\/research.0370","article-title":"Unlocking the Therapeutic Applicability of LNP-mRNA: Chemistry, Formulation, and Clinical Strategies","volume":"7","author":"Huang","year":"2024","journal-title":"Research"},{"key":"10.1016\/j.critrevonc.2026.105448_bib52","doi-asserted-by":"crossref","DOI":"10.1007\/s40259-026-00782-0","article-title":"Recent Developments in Lipid Nanoparticle-Mediated Delivery of Biotherapeutics and Gene Therapy Across the Blood-Brain Barrier","author":"Iqbal","year":"2026","journal-title":"BioDrugs"},{"issue":"24","key":"10.1016\/j.critrevonc.2026.105448_bib53","doi-asserted-by":"crossref","first-page":"6038","DOI":"10.3390\/molecules29246038","article-title":"Nanoconfined Chlorine-Substituted Monomethine Cyanine Dye with a Propionamide Function Based on the Thiazole Orange Scaffold-Use of a Fluorogenic Probe for Cell Staining and Nucleic Acid Visualization","volume":"29","author":"Ishkitiev","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.critrevonc.2026.105448_bib54","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.mtcomm.2018.09.011","article-title":"Novel nano therapeutic materials for the effective treatment of rheumatoid arthritis-recent insights","volume":"17","author":"Janakiraman","year":"2018","journal-title":"Mater. Today Commun."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105448_bib55","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.3390\/pharmaceutics14112520","article-title":"siRNA Functionalized Lipid Nanoparticles (LNPs) in Management of Diseases","volume":"14","author":"Kalita","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105448_bib56","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s42004-025-01699-5","article-title":"Spotlighting the criticality of lipid quality control through a mechanistic investigation of mRNA activity loss in lipid nanoparticles","volume":"8","author":"Kang","year":"2025","journal-title":"Commun. Chem."},{"issue":"22","key":"10.1016\/j.critrevonc.2026.105448_bib57","doi-asserted-by":"crossref","first-page":"10099","DOI":"10.1021\/acs.nanolett.3c03547","article-title":"Inhalable Gene Therapy and the Lung Surfactant Problem","volume":"23","author":"Kassab","year":"2023","journal-title":"Nano Lett."},{"key":"10.1016\/j.critrevonc.2026.105448_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114468","article-title":"Synthesis of a novel adapter lipid using Fc-region mediated antibody modification for post-insert preparation of transferrin receptor targeted messenger RNA-loaded lipid nanoparticles","volume":"203","author":"Kato","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.critrevonc.2026.105448_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.145854","article-title":"Antibody targeted delivery of lipid nanoparticles for RNA therapeutics to immune cells","volume":"320","author":"Kiaie","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105448_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202501401","article-title":"Advances in mRNA-Lipid Nanoparticle Engineering for Immune Cell Targeting and Immune Modulation","volume":"9","author":"Kim","year":"2025","journal-title":"Small Methods"},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105448_bib61","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3390\/pharmaceutics17101309","article-title":"Physiological Barriers to Nucleic Acid Therapeutics and Engineering Strategies for Lipid Nanoparticle Design, Optimization, and Clinical Translation","volume":"17","author":"Kim","year":"2025","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105448_bib62","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.1021\/acsomega.8b00341","article-title":"Development of the iLiNP Device: Fine Tuning the Lipid Nanoparticle Size within 10 nm for Drug Delivery","volume":"3","author":"Kimura","year":"2018","journal-title":"ACS Omega"},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105448_bib63","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105448_bib64","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/20415990.2025.2506977","article-title":"The role of excipients in lipid nanoparticle metabolism: implications for enhanced therapeutic effect","volume":"16","author":"Knaggs","year":"2025","journal-title":"Ther. Deliv."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105448_bib65","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1186\/s12951-024-02812-x","article-title":"Role of size, surface charge, and PEGylated lipids of lipid nanoparticles (LNPs) on intramuscular delivery of mRNA","volume":"22","author":"Kong","year":"2024","journal-title":"J. Nanobiotechnol"},{"key":"10.1016\/j.critrevonc.2026.105448_bib66","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.addr.2020.07.024","article-title":"Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals","volume":"154-155","author":"Kozma","year":"2020","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"45","key":"10.1016\/j.critrevonc.2026.105448_bib67","doi-asserted-by":"crossref","first-page":"21733","DOI":"10.1039\/C9NR09347H","article-title":"On the role of helper lipids in lipid nanoparticle formulations of siRNA","volume":"11","author":"Kulkarni","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.critrevonc.2026.105448_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fmedt.2025.1654003","article-title":"Nanoparticles: a new frontier in neurodegenerative disease therapy","volume":"7","author":"Kumar","year":"2025","journal-title":"Front. Med. Technol."},{"key":"10.1016\/j.critrevonc.2026.105448_bib69","article-title":"DNA aptamer-conjugated lipid nanoparticle for targeted PTEN mRNA delivery to prostate cancer cells","volume":"662","author":"Lee","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105448_bib70","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1021\/acs.molpharmaceut.5c00068","article-title":"Surface Plasmon Resonance Based Binding Characterization for Screening RNA-Loaded Lipid Nanoparticles (LNPs): Exploring Species Cross-Reactivity in LNP-Apolipoprotein E Interactions","volume":"22","author":"Lew","year":"2025","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105448_bib71","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1389201020666190924164152","article-title":"Lipid-based Vehicles for siRNA Delivery in Biomedical Field","volume":"21","author":"Li","year":"2020","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.critrevonc.2026.105448_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114027","article-title":"Efficacy versus immunogenicity of LNP-mediated delivery of mRNA and self-amplifying RNA upon intravitreal injection in the mouse eye","volume":"385","author":"Li","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.critrevonc.2026.105448_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113737","article-title":"Dimethylamino-based synthetic lipidoid nanoparticles for selective mRNA delivery to splenic antigen-presenting cells","volume":"382","author":"Liang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.critrevonc.2026.105448_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2026.102754","article-title":"Spleen-targeted neoantigen mRNA vaccine induces ISG15(+) CD8(+) T cell-mediated tertiary lymphoid structure formation in hepatocellular carcinoma,","author":"Lin","year":"2026","journal-title":"Cell. Rep. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105448_bib75","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41563-025-02320-9","article-title":"Tissue-specific mRNA delivery and prime editing with peptide-ionizable lipid nanoparticles","volume":"25","author":"Lin","year":"2026","journal-title":"Nat. Mater."},{"key":"10.1016\/j.critrevonc.2026.105448_bib76","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.biomaterials.2017.02.035","article-title":"Biomaterial-enabled delivery of SDF-1\u03b1 at the ventral side of breast cancer cells reveals a crosstalk between cell receptors to promote the invasive phenotype","volume":"127","author":"Liu","year":"2017","journal-title":"Biomaterials"},{"issue":"19","key":"10.1016\/j.critrevonc.2026.105448_bib77","doi-asserted-by":"crossref","first-page":"16007","DOI":"10.1021\/jacs.4c16326","article-title":"Furan-Derived Lipid Nanoparticles for Transporting mRNA to the Central Nervous System","volume":"147","author":"Liu","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.critrevonc.2026.105448_bib78","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.jconrel.2024.02.007","article-title":"Targeted delivery of polo-like kinase 1 siRNA nanoparticles using an EGFR-PEG bispecific antibody inhibits proliferation of high-risk neuroblastoma","volume":"367","author":"Logan","year":"2024","journal-title":"J. Control. Release"},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105448_bib79","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41551-021-00786-x","article-title":"Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs","volume":"5","author":"Lokugamage","year":"2021","journal-title":"Nat. Biomed. Eng."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105448_bib80","doi-asserted-by":"crossref","first-page":"7503","DOI":"10.1021\/nn202458g","article-title":"The evolution of the protein corona around nanoparticles: a test study","volume":"5","author":"Lundqvist","year":"2011","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105448_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104532","article-title":"Combinatorial chemistry and click chemistry for the optimization of lipid nanoparticles to enhance RNA delivery","volume":"30","author":"Ma","year":"2025","journal-title":"Drug. Discov. Today"},{"issue":"29","key":"10.1016\/j.critrevonc.2026.105448_bib82","doi-asserted-by":"crossref","first-page":"41666","DOI":"10.1021\/acsami.5c06927","article-title":"Microfluidic Production of Exosome-Mimicking Lipid Nanoparticles for Enhanced RNA Delivery: Role of Exosomal Proteins","volume":"17","author":"Maeki","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"Pt 1","key":"10.1016\/j.critrevonc.2026.105448_bib83","article-title":"Topical mutant allele-specific siRNA delivery for treatment of Meesmann epithelial corneal dystrophy and elucidation of disease biomarkers","volume":"388","author":"McLain","year":"2025","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105448_bib84","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41392-021-00642-z","article-title":"Membrane-destabilizing ionizable phospholipids: Novel components for organ-selective mRNA delivery and CRISPR-Cas gene editing","volume":"6","author":"Meng","year":"2021","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105448_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101493","article-title":"Preclinical toxicological assessment of an \u03b1-galactosylceramide-adjuvanted mRNA cancer vaccine in Wistar Han rats and domestic pigs","volume":"33","author":"Meulewaeter","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105448_bib86","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105448_bib87","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/nnano.2012.207","article-title":"Biomolecular coronas provide the biological identity of nanosized materials","volume":"7","author":"Monopoli","year":"2012","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105448_bib88","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/s41467-025-68103-7","article-title":"Multiplexed lipid nanoparticle barcoding reveals tissue-dynamic kinetic insights and enriched cellular tropism in hepatic zones","volume":"17","author":"Moore","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105448_bib89","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12951-016-0201-1","article-title":"Folate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migration","volume":"14","author":"Muralidharan","year":"2016","journal-title":"J. Nanobiotechnol"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105448_bib90","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307809121","article-title":"Electrostatic adsorption of polyanions onto lipid nanoparticles controls uptake, trafficking, and transfection of RNA and DNA therapies","volume":"121","author":"Nabar","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105448_bib91","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/cbdd.13978","article-title":"Specific delivering of RNAi using Spike's aptamer-functionalized lipid nanoparticles for targeting SARS-CoV-2: A strong anti-Covid drug in a clinical case study","volume":"99","author":"Nabiabad","year":"2022","journal-title":"Chem. Biol. Drug. Des."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105448_bib92","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1021\/acs.molpharmaceut.7b01055","article-title":"Systemic Administration of siRNA with Anti-HB-EGF Antibody-Modified Lipid Nanoparticles for the Treatment of Triple-Negative Breast Cancer","volume":"15","author":"Okamoto","year":"2018","journal-title":"Mol. Pharm."},{"issue":"18","key":"10.1016\/j.critrevonc.2026.105448_bib93","doi-asserted-by":"crossref","first-page":"10240","DOI":"10.1039\/D0NR02788J","article-title":"Protein corona fingerprinting to differentiate sepsis from non-infectious systemic inflammation","volume":"12","author":"Papafilippou","year":"2020","journal-title":"Nanoscale"},{"issue":"16","key":"10.1016\/j.critrevonc.2026.105448_bib94","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202201095","article-title":"Anionic Lipid Nanoparticles Preferentially Deliver mRNA to the Hepatic Reticuloendothelial System","volume":"34","author":"Pattipeiluhu","year":"2022","journal-title":"Adv. Mater."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105448_bib95","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.ymthe.2018.03.010","article-title":"A Novel Amino Lipid Series for mRNA Delivery: Improved Endosomal Escape and Sustained Pharmacology and Safety in Non-human Primates","volume":"26","author":"Sabnis","year":"2018","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105448_bib96","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jconrel.2010.01.036","article-title":"Endocytosis of nanomedicines","volume":"145","author":"Sahay","year":"2010","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105448_bib97","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1021\/acs.molpharmaceut.0c00087","article-title":"Improved Stability of siRNA-Loaded Lipid Nanoparticles Prepared with a PEG-Monoacyl Fatty Acid Facilitates Ligand-Mediated siRNA Delivery","volume":"17","author":"Sakurai","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.critrevonc.2026.105448_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2024.103101","article-title":"The biomolecular corona of nanomedicines: effects on nanomedicine outcomes and emerging opportunities","volume":"87","author":"Salvati","year":"2024","journal-title":"Curr. Opin. Biotechnol."},{"issue":"35","key":"10.1016\/j.critrevonc.2026.105448_bib99","doi-asserted-by":"crossref","first-page":"45871","DOI":"10.1021\/acsami.4c04893","article-title":"Antisense Oligonucleotide Embedded Context Responsive Nanoparticles Derived from Synthetic Ionizable Lipids for lncRNA Targeted Therapy of Breast Cancer","volume":"16","author":"Sarkar","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105448_bib100","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1248\/bpb.b24-00898","article-title":"Systemic mRNA Delivery into the Muscle of Duchenne Muscular Dystrophy Model Mice Using Alpha-Dystroglycan Binding Peptide Modified Lipid Nanoparticles","volume":"48","author":"Sasaki","year":"2025","journal-title":"Biol. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105448_bib101","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00403-025-03971-z","article-title":"Unravelling the complexity of CARPA: a review of emerging advancements in therapeutic strategies","volume":"317","author":"Saxena","year":"2025","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.critrevonc.2026.105448_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120586","article-title":"mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability","volume":"601","author":"Schoenmaker","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105448_bib103","doi-asserted-by":"crossref","first-page":"7263","DOI":"10.1038\/s41467-024-51571-8","article-title":"RNA nanotherapeutics with fibrosis overexpression and retention for MASH treatment","volume":"15","author":"Shan","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105448_bib104","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jconrel.2024.03.056","article-title":"mRNA therapies: Pioneering a new era in rare genetic disease treatment","volume":"369","author":"Shen","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.critrevonc.2026.105448_bib105","doi-asserted-by":"crossref","first-page":"8395","DOI":"10.2147\/IJN.S188016","article-title":"Mixing lipids to manipulate the ionization status of lipid nanoparticles for specific tissue targeting","volume":"13","author":"Shobaki","year":"2018","journal-title":"Int. J. Nanomed."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105448_bib106","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41563-019-0566-2","article-title":"The entry of nanoparticles into solid tumours","volume":"19","author":"Sindhwani","year":"2020","journal-title":"Nat. Mater."},{"issue":"15","key":"10.1016\/j.critrevonc.2026.105448_bib107","doi-asserted-by":"crossref","first-page":"6584","DOI":"10.1021\/acs.nanolett.1c01973","article-title":"Lipid Nanoparticle Spherical Nucleic Acids for Intracellular DNA and RNA Delivery","volume":"21","author":"Sinegra","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.critrevonc.2026.105448_bib108","article-title":"A Review of Nanoparticle-Mediated Delivery Systems for RNA-Based Therapeutics","author":"Sivamaruthi","year":"2025","journal-title":"Recent. Pat. Nanotechnol."},{"issue":"44","key":"10.1016\/j.critrevonc.2026.105448_bib109","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202401445","article-title":"Tuning Lipid Nanoparticles for RNA Delivery to Extrahepatic Organs","volume":"36","author":"Song","year":"2024","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105448_bib110","doi-asserted-by":"crossref","first-page":"8522","DOI":"10.1038\/s41467-025-63553-5","article-title":"Ocular delivery of lipid nanoparticles-formulated mRNA encoding lanosterol synthase ameliorates cataract in rats","volume":"16","author":"Song","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105448_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2025.114762","article-title":"Impurity profiling of PEGylated myristoyl diglyceride, DMG-PEG 2000, a functional excipient used in mRNA lipid nanoparticle formulations","volume":"214","author":"Sperber","year":"2025","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.critrevonc.2026.105448_bib112","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-026-01640-8","article-title":"Artificial intelligence-guided design of LNPs for in vivo targeted mRNA delivery via analysis of the spatial conformation of ionizable lipids","author":"Su","year":"2026","journal-title":"Nat. Biomed. Eng."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105448_bib113","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202415643","article-title":"Modular Design of Lipopeptide-Based Organ-Specific Targeting (POST) Lipid Nanoparticles for Highly Efficient RNA Delivery","volume":"37","author":"Tang","year":"2025","journal-title":"Adv. Mater."},{"issue":"Pt 4","key":"10.1016\/j.critrevonc.2026.105448_bib114","article-title":"Current state of RNA delivery using lipid nanoparticles to extrahepatic tissues: A review towards clinical translation","volume":"242","author":"Truong","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105448_bib115","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1073\/pnas.95.4.1466","article-title":"Membrane targeting of cGMP-dependent protein kinase is required for cystic fibrosis transmembrane conductance regulator Cl- channel activation","volume":"95","author":"Vaandrager","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.critrevonc.2026.105448_bib116","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jconrel.2024.07.044","article-title":"Biofluid specific protein coronas affect lipid nanoparticle behavior in vitro","volume":"373","author":"van Straten","year":"2024","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105448_bib117","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01775-23","article-title":"Circular RNA vaccines with long-term lymph node-targeting delivery stability after lyophilization induce potent and persistent immune responses","volume":"15","author":"Wan","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.critrevonc.2026.105448_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114472","article-title":"Enhancing lipid nanoparticles-mediated RNA delivery to glioblastoma via targeted strategies","volume":"389","author":"Wang","year":"2026","journal-title":"J. Control. Release"},{"key":"10.1016\/j.critrevonc.2026.105448_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107383","article-title":"Impact of formulation and process parameters on the stability and bioactivity of RNA-loaded lipid nanoparticles during nebulization","volume":"216","author":"Wiebe","year":"2026","journal-title":"Eur. J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105448_bib120","doi-asserted-by":"crossref","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.critrevonc.2026.105448_bib121","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.addr.2020.06.026","article-title":"Lipid nanoparticle technology for therapeutic gene regulation in the liver","volume":"159","author":"Witzigmann","year":"2020","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"47","key":"10.1016\/j.critrevonc.2026.105448_bib122","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2518418122","article-title":"The liver talks back: NPY orchestrates attraction of cancer cells and CHK2-dependent clonogenicity in the metastatic niche","volume":"122","author":"Wormser","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.critrevonc.2026.105448_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125520","article-title":"Process development of tangential flow filtration and sterile filtration for manufacturing of mRNA-lipid nanoparticles: A study on membrane performance and filtration modeling","volume":"675","author":"Wu","year":"2025","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105448_bib124","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/j.cell.2026.01.012","article-title":"LUMI-lab: A foundation model-driven autonomous platform enabling discovery of ionizable lipid designs for mRNA delivery","volume":"189","author":"Xu","year":"2026","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105448_bib125","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1021\/jacs.4c10265","article-title":"Multiarm-Assisted Design of Dendron-like Degradable Ionizable Lipids Facilitates Systemic mRNA Delivery to the Spleen","volume":"147","author":"Xue","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.critrevonc.2026.105448_bib126","article-title":"Novel bionic inspired nanosystem construction for precise delivery of mRNA","volume":"11","author":"Yang","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.critrevonc.2026.105448_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2025.108546","article-title":"Targeted delivery systems of siRNA based on ionizable lipid nanoparticles and cationic polymer vectors","volume":"81","author":"Yao","year":"2025","journal-title":"Biotechnol. Adv."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105448_bib128","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202202127","article-title":"Lipid Nanoparticle Delivery of Chemically Modified NGF(R100W) mRNA Alleviates Peripheral Neuropathy","volume":"12","author":"Yu","year":"2023","journal-title":"Adv. Healthc. Mater."},{"issue":"43","key":"10.1016\/j.critrevonc.2026.105448_bib129","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adx5970","article-title":"Ionizable guanidine-based lipid nanoparticle for targeted mRNA delivery and cancer immunotherapy","volume":"11","author":"Zhang","year":"2025","journal-title":"Sci. Adv."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105448_bib130","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2314747121","article-title":"Precision treatment of viral pneumonia through macrophage- targeted lipid nanoparticle delivery","volume":"121","author":"Zhao","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.critrevonc.2026.105448_bib131","article-title":"Engineering age-adaptive mRNA lipid nanoparticle cancer vaccines via reprogramming systemic gene expression","author":"Zhu","year":"2026","journal-title":"bioRxiv"},{"key":"10.1016\/j.critrevonc.2026.105448_bib132","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jconrel.2022.09.021","article-title":"Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery","volume":"351","author":"Zimmermann","year":"2022","journal-title":"J. Control. Release"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826003355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826003355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:35:35Z","timestamp":1793943335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826003355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":132,"alternative-id":["S1040842826003355"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105448","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting strategies of lipid nanoparticles for RNA therapeutics: From hepatic tropism to extrahepatic precision delivery","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105448","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105448"}}